CLGN

Companies
NASDAQ
CollPlant Biotechnologies Ltd.
Health Care
Price Chart
Overview

About CLGN

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.

Market Cap
$58.8M
Volume
14.6K
Avg. Volume
19.0K
P/E Ratio
-4.435898
Dividend Yield
0.00%
Employees
71.0

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Biotechnology
Risk & Correlation Analysis
Market Correlation
0.45
Low Correlation
Volatility
High (0.55)
Relative to market

Macro Factor Sensitivities

Interest Rates
Low Sensitivity
Inflation
Medium Sensitivity
GDP Growth
High Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for CLGN.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, CLGN shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$58.8M
Volume14.6K
P/E Ratio-4.44
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 27, 2025
Related Securities

PortfolioPilot Analysis

Get AI-powered insights on how CLGN fits into your investment strategy and portfolio diversification.

Pricing info last updated June 17, 2025 (after market close)Other info last updated April 2, 2025